cashed up, ready to make medical history, page-29

I posted this 3/2/14 @.84c

spoke with the company today.

There is NO issue with the patents running out in 2018 - as Pfizer incorporated new patents into the HCV program at the time of the collaboration between Tacere Therapeutics (acquired by Benitec in October 2012) and Pfizer.

These new patents protect us/run out in 2028.

There will be an announcement to the market once the first patent is dosed as it will be a very significant moment for the company.